An in-depth look at the most common observations from recent FDA 483s and EMA GMP deficiency reports — with practical guidance on how companies can proactively address gaps before inspectors arrive. Covers data integrity, CAPA quality, training records, and SOP management. Written for quality directors and site heads at pharmaceutical manufacturing facilities.
